{"_canonicalization":{"envelope_id":"axm_ + sha256(envelope minus {signature, axiom_id, anchors})","envelope_signature":"ed25519(envelope minus {signature, axiom_id})","json":"sort_keys=True, separators=(',',':'), ensure_ascii=False, allow_nan=False, utf-8","leaf_hash":"sha256(0x00 || canonical_json(envelope_full))","seal_signature":"ed25519(seal minus {signature, sig_algorithm})"},"axiom_id":"axm_ba04fc021cb0f150c33a97df59dd4c68beb92a592b4b3897f55b9c3805db1166","bitcoin_anchor":{"bitcoin_attestations":[],"calendar_attestations":[],"ots_url":"","stamped_at":"","status":"pending_next_stamp"},"envelope":{"anchors":[{"chain":"crovia.axiom_graph","height":0,"merkle_proof":"spider_vendor_press_v1","root_at_anchor":"spider_vendor_press_v1"}],"axiom_id":"axm_ba04fc021cb0f150c33a97df59dd4c68beb92a592b4b3897f55b9c3805db1166","axiom_type":"AX.OBS","body":{"axiom_subtype":"news.vendor_press.v1","category":"news","fingerprint":"bd9b1b60a9d74a23e9c47d8d17bcf8137e47c128e2c78f186fc2569ffd888c8c","published":"Thu, 04 Jun 2026 00:00:00 -0400","receipt_hash":"bd9b1b60a9d74a23e9c47d8d17bcf8137e47c128e2c78f186fc2569ffd888c8c","schema":"spider.news.vendor_press.v1","spider":"vendor_press","spider_record":{"axiom_subtype":"news.vendor_press.v1","category":"news","decision_hint":"POSITIVE","envelope_target":"AX.OBS","fingerprint":"bd9b1b60a9d74a23e9c47d8d17bcf8137e47c128e2c78f186fc2569ffd888c8c","observed_at":"2026-06-04T04:43:08.243501Z","parent_run_hash":"298818240313a3c9ce3ace3750dbf55845013dc3bc59aeced6331eccefdb61ac","published":"Thu, 04 Jun 2026 00:00:00 -0400","runtime_version":"0.1.0","schema":"spider.news.vendor_press.v1","source_status":200,"source_url":"https://export.arxiv.org/rss/cs.AI","spider":"vendor_press","summary_excerpt":"arXiv:2606.03995v1 Announce Type: cross \nAbstract: Background: Alzheimer's disease (AD) affects over 55 million people worldwide. Accurate, interpretable detection of normal cognition (NC), mild cognitive impairment (MCI), and AD from routine clinical assessments remains a critical unmet need. Methods: An XGBoost classifier was developed for three-class detection using eight clinical features from the Alzheimer's Disease Neuroimaging Initiative (ADNI): MMSE, CDR Global, CDR Sum of Boxes (CDR-SB), MoCA, FAQ, age, sex, and education. Hyperparameters were optimised using Optuna (50 trials); class imbalance was addressed with SMOTE. Performance was evaluated by macro AUC-ROC with 1,000-iteration bootstrap 95% confidence intervals, macro F1, balanced accuracy, and Cohen's kappa. SHAP values provided feature-level explainability. Results: The dataset comprised 1,641 baseline subjects (608 NC, 767 MCI, 266 AD). On five-fold cross-validation, mean macro AUC was 0.983 (SD 0.007), accuracy 0.944","title":"Early Detection of Alzheimer's Disease Using Explainable Machine Learning on Clinical Biomarkers: A Multi-Class Classification Study Using the Alzheimer's Disease Neuroimaging Initiative (ADNI) Dataset","url":"https://arxiv.org/abs/2606.03995","vendor":"arxiv_cs_ai"},"summary":"arXiv:2606.03995v1 Announce Type: cross \nAbstract: Background: Alzheimer's disease (AD) affects over 55 million people worldwide. Accurate, interpretable detection of normal cognition (NC), mild cognitive impairment (MCI), and AD from routine clinical assessments remains a critical unmet need. Methods: An XGBoost classifier was developed for three-class detection using eight clinical features from the Alzheimer's Disease Neuroimaging Initiative (ADNI): MMSE, CDR Global, CDR Sum of Boxes (CDR-SB), MoCA, FAQ, age, sex, and education. Hyperparameters were optimised using Optuna (50 trials); class imbalance was addressed with SMOTE. Performance was evaluated by macro AUC-ROC with 1,000-iteration bootstrap 95% confidence intervals, macro F1, balanced accuracy, and Cohen's kappa. SHAP values provided feature-level explainability. Results: The dataset comprised 1,641 baseline subjects (608 NC, 767 MCI, 266 AD). On five-fold cross-validation, mean macro AUC was 0.983 (SD 0.007), accuracy 0.944","title":"Early Detection of Alzheimer's Disease Using Explainable Machine Learning on Clinical Biomarkers: A Multi-Class Classification Study Using the Alzheimer's Disease Neuroimaging Initiative (ADNI) Dataset","vendor":"arxiv_cs_ai"},"confidence":{"method":"deterministic"},"decision":"POSITIVE","issued_at":"2026-06-04T04:43:08Z","notes":"Spider vendor_press (news) news.vendor_press.v1","object":{"captured_by":"crovia.spider.vendor_press","primary_source_url":"https://arxiv.org/abs/2606.03995"},"predecessors":[],"schema":"crovia.axiom.v1","signature":"ed25519:ea4cc8e596720ee2c05aa852a74642d53e17f1245564070875ba9989fc8fadb4827eafd5f11041b0f85e554ed3eb84584b5d2ef8bf52284b6183845cf08d9709","signer":"crovia.substrate","subject":{"observed_at":"2026-06-04T04:43:08Z","source_collector":"spider:vendor_press","target_id":"https://arxiv.org/abs/2606.03995"},"tsa":{"authority":"crovia.substrate.bootstrap","rfc3161_token":"{\"kind\":\"crovia.bootstrap.tsa\",\"source_jsonl\":\"/opt/crovia/spider/data/news/vendor_press_v1.jsonl\",\"source_seal_merkle_root\":\"spider_vendor_press_v1\",\"upgrade_path\":\"Sessione H \\u2014 OpenTimestamps weekly anchor\"}"},"zk_mode":"clear","zk_proof":null},"ledger":{"leaf_hash":"13b48d9946216ff3a68ec96d8725d83434e48970b1214c4d61ed2f118554cfb5","leaf_index":212601,"ledger_path":"/opt/crovia/substrate/axiom_ledger.jsonl"},"merkle_proof":{"hash_alg":"sha256","leaf_prefix":"0x00","node_prefix":"0x01","odd_leaf_rule":"duplicate_last","path":[{"sibling":"05b7737b1ff1fee5a7e5f020e88cacbeb244c56a7fe679e87556d5d91de1adae","side":"left"},{"sibling":"1d59f71ed81131732e75e6ff98f1c6a564e4be8c691dec84ff75e5306bcb0c46","side":"right"},{"sibling":"aba1ac2df5da8d6623ead4ad1dcdb0ce8e16b2c86ad78dd40e462e5c2b899ff1","side":"right"},{"sibling":"4e2117bf31249ecab286364808ae795eab0d1670fec1c4a53c3e70b407e736e2","side":"left"},{"sibling":"f17705d54953e005f498297ae645297bb8c4f9c9c62f1f6771d456f6d4b72be3","side":"left"},{"sibling":"67bd992e7031dff11ba44bd6f13b27a8a346998c61a78efa58eed6e8c1a4384a","side":"left"},{"sibling":"a49f13ca87d28137189285c4f8198910099d3f96a052e19c053d3f3d55fc92fb","side":"left"},{"sibling":"a1d8ffdfa1c0f13e012e679efbd699e2e3793ae4e9c41ad2dd5585116e4e10ee","side":"right"},{"sibling":"c78f0d662697b816291c956749c41d06c16e4dc4c3d390f9a90590e3f2821765","side":"right"},{"sibling":"cfb460164a914d1f96a36aa17124b45bb5417829d2adbe5ca48375dbd842ec44","side":"left"},{"sibling":"a84ebc8e894a9893ee34d1afc942d15f28243b926f1e5f9d7f10a3de1e795262","side":"left"},{"sibling":"f8f6bd9da448fa097e2115b71146f61691d9f8807aca291c87c633192a7224e9","side":"left"},{"sibling":"2dca509b3eb767a47cf215d4315f230ce9103a76264412008ae23a349b519ef1","side":"left"},{"sibling":"24d1bb4b13e0e46131b27b70a48e65fcf4e2e14b95e3bb83ade821e9df530f6b","side":"left"},{"sibling":"422bcf7e281ca3a607f3726a5e6b8fabdb85e8b32199b4a86356998e260a0b34","side":"right"},{"sibling":"54a99163a4a62374c3ca6fb46294222f1d4b1a9d0b636e27256b0e093e98239a","side":"right"},{"sibling":"c300cf0154c136afc09b1702a0be98f4ba5b6dc5cf57e8cc714ec1eaf4196eff","side":"left"},{"sibling":"d841ad93efda0869e5eb97678f348f03f5caab4353e05ff4bf18f47fb945b822","side":"left"}]},"schema":"crovia.axiom_proof.v1","seal":{"first_collector_run_id":"","first_receipt_hash":"","jsonl_path":"/opt/crovia/substrate/axiom_ledger.jsonl","key_id":"430895f101d38164","last_collector_run_id":"","last_receipt_hash":"","leaf_count":213053,"merkle_root":"19d104b92c4d7299881c447fb8422611fc9cb8615d37a538959e34a2da7ef55f","public_key_hex":"cf742e26f75669dc673cb5c0786a1ae23ae8ca19c347317192ce40c28a7ff25c","run_id":"hourly_json_retrofit_20260604T053701Z","schema":"crovia.seal.v1","seal_family_version":"crovia-seal-family/1","seal_kind":"substrate_batch","sealed_at":"2026-06-04T05:37:49Z","sig_algorithm":"ed25519","signature":"630748e88645187aa3b4d4cb8c872cc146180d0301e4c6656f15f99081d7776432715cea2a997b32b7b3a5216f215d19c1b536c0b093100ec843fa0bd65f2101","signer_version":"1.1.0"},"trust_root":{"key_id":"430895f101d38164","public_key_hex":"cf742e26f75669dc673cb5c0786a1ae23ae8ca19c347317192ce40c28a7ff25c","signature_algorithm":"ed25519","url":"/registry/canon/TRUST_ROOT.md"},"verifier":{"spec":"/registry/canon/AXIOM_RECEIPT_v1.md","url":"/v/axm_ba04fc021cb0f150c33a97df59dd4c68beb92a592b4b3897f55b9c3805db1166"}}